Xeris Biopharma Holdings (XERS) Equity Ratio: 2020-2025
Historic Equity Ratio for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to -0.00.
- Xeris Biopharma Holdings' Equity Ratio rose 97.36% to -0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.00, marking a year-over-year increase of 97.36%. This contributed to the annual value of -0.09 for FY2024, which is 336.05% down from last year.
- Per Xeris Biopharma Holdings' latest filing, its Equity Ratio stood at -0.00 for Q3 2025, which was up 95.97% from -0.06 recorded in Q2 2025.
- Xeris Biopharma Holdings' 5-year Equity Ratio high stood at 0.31 for Q4 2021, and its period low was -0.11 during Q1 2025.
- In the last 3 years, Xeris Biopharma Holdings' Equity Ratio had a median value of -0.03 in 2024 and averaged -0.03.
- In the last 5 years, Xeris Biopharma Holdings' Equity Ratio skyrocketed by 1,068.80% in 2022 and then tumbled by 848.05% in 2024.
- Quarterly analysis of 5 years shows Xeris Biopharma Holdings' Equity Ratio stood at 0.31 in 2021, then slumped by 58.08% to 0.13 in 2022, then plummeted by 116.03% to -0.02 in 2023, then plummeted by 336.05% to -0.09 in 2024, then skyrocketed by 97.36% to -0.00 in 2025.
- Its last three reported values are -0.00 in Q3 2025, -0.06 for Q2 2025, and -0.11 during Q1 2025.